Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer. (Q51238587)

1 April 2018

title

Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer. (English)

1 reference

1 April 2018

author name string

Zhenghui Guo

1

1 reference

1 April 2018

Xianju Chen

2

1 reference

1 April 2018

Tao Du

3

1 reference

1 April 2018

Dingjun Zhu

4

1 reference

1 April 2018

Yiming Lai

5

1 reference

1 April 2018

Wen Dong

6

1 reference

1 April 2018

Wanhua Wu

7

1 reference

1 April 2018

Chunhao Lin

8

1 reference

1 April 2018

Leyuan Liu

9

1 reference

1 April 2018

Hai Huang

10

1 reference

1 April 2018

publication date

23 December 2016

1 reference

1 April 2018

published in

Medical Oncology

1 reference

1 April 2018

volume

34

1 reference

1 April 2018

issue

1

1 reference

1 April 2018

page(s)

13

1 reference

1 April 2018

Global cancer statistics, 2012

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

21 January 2018

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Prevention and early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Medium-term outcomes of active surveillance for localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

International variation in prostate cancer incidence and mortality rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Chromosomal Localization of the Human ECT2 Proto-oncogene to 3q26.1 → q26.2 by Somatic Cell Analysis and Fluorescence in Situ Hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Oncogene ect2 is related to regulators of small GTP-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Changes in Ect2 localization couple actomyosin-dependent cell shape changes to mitotic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

An ECT2-centralspindlin complex regulates the localization and function of RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Pebble/ECT2 RhoGEF negatively regulates the Wingless/Wnt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

21 January 2018

Rho GTPases and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Autophagy-mediated tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

Evolutionary trends and functional anatomy of the human expanded autophagy network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-016-0872-3

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/28012134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeting of the RhoGEF Ect2 to the equatorial membrane controls cleavage furrow formation during cytokinesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28012134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-016-0872-3

1 reference

1 April 2018

1 reference

1 April 2018